Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Table 1 Definition of patients in each subgroup

Subgroup	Patient characteristics
Group 1	Normal weight patients without HBV infection
Group 2	Normal weight patients combined HBV infection
Group 3	Overweight patients without HBV infection
Group 4	Overweight patients combined HBV infection

ISSN: 1471-2407